Gilead

FDA calls out 39 drug companies for allegedly blocking access to generics
FDA calls out 39 drug companies for allegedly blocking access to generics
Stat
JNJ
Actelion
Celgene
Gilead
Novartis
Pfizer
Valeant Pharmaceuticals
generics
FDA
Flag link:
HIV Patients File Class Action and Personal Injury Lawsuits for California Patients Against Gilead
Gilead
lawsuits
AIDS
Flag link:
Gilead and Alphabet's Verily to Collaborate on Research in Immunological and Molecular Drivers of Inflammatory Diseases
Gilead
Verily
Flag link:
Gilead Presents Data on Multiple Investigational Regimens for the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Gilead
NASH
selonsertib
GS-9674
GS-0976
Flag link:
J&J lines up its 4-in-1 HIV pill for FDA behind rivals from Gilead, GSK
J&J lines up its 4-in-1 HIV pill for FDA behind rivals from Gilead, GSK
Endpoints
JNJ
HIV
Gilead
GSK
FDA
D/C/F/TAF
Flag link:
Big Biotech is here — and it’s starting to look a lot like Big Pharma
Big Biotech is here — and it’s starting to look a lot like Big Pharma
Stat
biotech
Big Pharma
Big Biotech
BIO 2016
Gilead
Celgene
Flag link:
Patent Troubles Hit Biogen After Gilead, Regeneron; What’s Next?
Patent Troubles Hit Biogen After Gilead, Regeneron; What’s Next?
Bidness, ETC
Biogen
Gilead
Regeneron
patents
Tecfidera
Harvoni
Sovaldi
Flag link:
Will Merck Encroach On Gilead's Harvoni Territory?
Will Merck Encroach On Gilead's Harvoni Territory?
Yahoo/Benzinga
Merck
Gilead
Harvoni
AbbVie
hepatitis C
Viekira Pak
Zepatier
Flag link:
AbbVie Not Worried About Humira Biosimilars
AbbVie Not Worried About Humira Biosimilars
Bidness, ETC
AbbVie
Humira
biosimilars
Gilead
Pfizer
Novartis
Amgen
Flag link:
Gilead combo drug fights all forms of hep C infection: data
Gilead combo drug fights all forms of hep C infection: data
Yahoo/Reuters
Gilead
hepatitis C
velpatasvir
Sovaldi
Flag link:
Will Gilead Sciences (GILD) Stock Fall on Fewer Hep-C Prescriptions?
Will Gilead Sciences (GILD) Stock Fall on Fewer Hep-C Prescriptions?
TheStreet.com
Gilead
hepatitis C
Harvoni
Sovaldi
Flag link:
Gilead Sciences Ready To Face Complera Patent War With Mylan
Gilead Sciences Ready To Face Complera Patent War With Mylan
Bidness, ETC
Gilead
Complera
patents
Mylan Labs
generics
Flag link:
Gilead banks $10B, stirring fresh buzz about a blockbuster buyout
Gilead banks $10B, stirring fresh buzz about a blockbuster buyout
Fierce Biotech
Gilead
M&A
Flag link:
Why Gilead's hep C scripts are slowing down in Q3
Why Gilead's hep C scripts are slowing down in Q3
BioPharma Dive
Gilead
hepatitis C
Harvoni
Sovaldi
Flag link:
Analysts: Gilead's hep C scripts keep slowing, and Q3 sales forecasts should too
Analysts: Gilead's hep C scripts keep slowing, and Q3 sales forecasts should too
Fierce Pharma
Gilead
Sovaldi
Harvoni
hepatitis C
Flag link:
How Big Biotech Spents It’s Money
How Big Biotech Spents It’s Money
Barron's
biotech
Amgen
Biogen
Regeneron
Celgene
Gilead
Alexion
Flag link:
ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance Sheet
ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance Sheet
Seeking Alpha
GSK
ViiV Healthcare
Gilead
Pfizer
Bristol-Myers Squibb
HIV
Flag link:
Gilead hepatitis C drugs build road to Japan
Gilead hepatitis C drugs build road to Japan
Bizjournals.com
Gilead
Japan
hepatitis C
Harvoni
Sovaldi
Flag link:
China rejects Gilead hepatitis C drug patent -advocacy group
China rejects Gilead hepatitis C drug patent -advocacy group
Yahoo/Reuters
China
Gilead
hepatitis C
generics
Flag link:
Gilead’s $1,000 Pill Is Hard for States to Swallow
Gilead’s $1,000 Pill Is Hard for States to Swallow
WSJ Online
Gilead
hepatitis C
drug pricing
Harvoni
Sovaldi
Flag link:

Pages